Industry News

Member News:

September 28, 2012- RJ Lee Group Provides Training to the U.S. FDA on Managing Foreign Particulate Contamination in Pharmaceuticals
November 5, 2012 - Approval for rapid diagnostic for foodborne pathogen has ramifications for healthcare
November 16, 2012- PolyMedix Announces Successful Meeting with the FDA for Brilacidin
December 17, 2012- Fibrocell Science Announces a New Clinical Trial for Restrictive Burn Scars

Industry News:

PennsylvaniaBio

BioNJ Announces Keynote Speakers for BioP 4th Annual International BioPartnering Conference May 24, 2013
TRENTON, N.J.--(BUSINESS WIRE)--BioNJ’s 4th International BioPartnering Conference on June 17 at The Westin Princeton is the only meeting of its kind in NJ. Network and find business opportunities with global life science companies. […]
Antares Pharma to Present at the Deutsche Bank Securities, Inc. 38th Annual Health Care Conference May 24, 2013
EWING, N.J.--(BUSINESS WIRE)--Antares Pharma, Inc. (NASDAQ: ATRS) today announced that Paul K. Wotton, Ph.D., President and Chief Executive Officer, will present at the Deutsche Bank Securities, Inc. 38th Annual Health Care Conference on Thursday May 30, 2013 at 10:40 am Eastern Time. A live webcast of the presentation will be available via the “Investor Rel […]
Advaxis Announces Filing of Proxy Statement Supplement and New Annual Meeting Date May 23, 2013
PRINCETON, N.J.--(BUSINESS WIRE)--Advaxis, Inc., (OTCBB: ADXS), a leader in developing the next generation of immunotherapies for cancer and infectious diseases, announced that it has filed a Form DEFR14A, proxy statement supplement, with the U.S. Securities and Exchange Commission. The filing revises certain proposals in the proxy statement originally filed […]
Further Data on STENTYS Self-Apposing Stent Reinforces Strength of Clinical Results May 22, 2013
PRINCETON, N.J. & PARIS--(BUSINESS WIRE)--The STENTYS Self-Apposing Stent performs equally well in many subgroups, according to a new analysis from a 1,000 patient trial assessing the stent in heart attack patients presented at EuroPCR. […]
Clinical Data on TetraLogic Pharmaceuticals’ Smac Mimetic Birinapant to Be Presented at ASCO May 22, 2013
MALVERN, Pa.--(BUSINESS WIRE)--TetraLogic Pharmaceuticals, a biopharmaceutical company developing novel small molecule Smac mimetic drugs to treat cancer, today announced that data from two clinical studies investigating its lead Smac mimetic drug candidate birinapant (formerly TL32711) will be presented at the 2013 Annual Meeting of the American Society of […]
Incyte to Present at Upcoming Investor Conferences May 22, 2013
WILMINGTON, Del.--(BUSINESS WIRE)--Incyte Corporation (Nasdaq:INCY) announced today it will present at the following investor conferences during the month of June: Jefferies 2013 Global Healthcare Conference on Thursday, June 6, 2013 at 12:30 pm (EDT) in New York; Goldman Sachs 34th Annual Global Healthcare Conference on Tuesday, June 11, 2013 at 3:20 pm (PD […]
Four Integrated Health Systems Form New Premier healthcare alliance Collaborative, Save $5.4 Million May 21, 2013
CHARLOTTE, N.C.--(BUSINESS WIRE)--Four integrated health systems form new Premier collaborative, save $5.4 million […]
Phase III results: tiotropium* Respimat® effective in symptomatic asthma patients despite at least ICS†/LABA‡ independent of their age, allergic status, smoking status and bronchodilator response May 21, 2013
PHILADELPHIA--(BUSINESS WIRE)--Data from the PrimoTinA-asthma Phase III studies being presented for the first time at the 2013 American Thoracic Society (ATS) congress in Philadelphia, Pennsylvania. […]
From Novel Research to Innovative Medicines: GlaxoSmithKline Launches Discovery Fast Track Competition for Academic Researchers May 21, 2013
PHILADELPHIA--(BUSINESS WIRE)--GSK launches a competition for academic investigators in the US and Canada whereby winners will have an opportunity to collaborate with GSK with the goal of translating a novel idea into a medicine. […]
STENTYS Enrolls First Heart Attack Patient in Pivotal U.S. Clinical Trial May 20, 2013
PRINCETON, N.J. & PARIS--(BUSINESS WIRE)--STENTYS has treated the first heart attack patient in a U.S. clinical trial to compare the STENTYS Self-Apposing Stent to the Abbott Multi-Link Stent at one year post-procedure. […]